Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ocean 1181
Providence, Rhode Island, United States
- Ownership
- Private
- Employees
- ~8
- Development stage
- Other
01
Overview
Ocean Biomedical is advancing preclinical programs in cancer immunotherapy, anti-fibrosis, and malaria, with recent positive preclinical data and proprietary patents in anti-CHI3L1 and anti-fibrosis modalities
- Therapeutic areas
- OncologyInfectious DiseasesRare DiseasesPulmonology
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodySmall moleculeVaccine
- Industry
- Biotech
02
Partnerships
Virion Therapeutics (joint venture for oncology/infectious disease work)Academic and medical research institutions (including Brown University, Yale University indirectly via founders)
Beyond the preview
Go deeper on Ocean 1181.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ocean 1181.